Cantel Medical Corp. to Present at the UBS Global Life Sciences Conference
September 10 2009 - 8:30AM
PR Newswire (US)
LITTLE FALLS, N.J., Sept. 10 /PRNewswire-FirstCall/ -- CANTEL
MEDICAL CORP. (NYSE:CMN) announced today that Andrew A. Krakauer,
President & CEO, will be presenting at the UBS Global Life
Sciences Conference. The formal presentation is scheduled for 9:00
AM ET on Tuesday, September 22, 2009 at the Grand Hyatt New York,
with a Q & A session immediately following the presentation. In
addition, Mr. Krakauer and Seth R. Segel, Executive Vice President,
will be available for separate one-on-one meetings during the day.
The presentation will be available on the Investor Relations
section of the company's website: http://www.cantelmedical.com/.
Cantel Medical Corp. (NYSE:CMN) is a leading provider of infection
prevention and control products in the healthcare market. Our
products include specialized medical device reprocessing systems
for renal dialysis and endoscopy, dialysate concentrates and other
dialysis supplies, disposable infection control products primarily
for the dental industry, water purification equipment, sterilants,
disinfectants and cleaners, hollow fiber membrane filtration and
separation products for medical and non-medical applications, and
specialty packaging for infectious and biological specimens. We
also provide technical maintenance for our products and offer
compliance training services for the transport of infectious and
biological specimens. For more information please visit
http://www.cantelmedical.com/ DATASOURCE: Cantel Medical Corp.
CONTACT: Andrew A. Krakauer, President & CEO, Cantel Medical
Corp., +1-973-890-7220; or Richard E. Moyer, Cameron Associates,
Inc., +1-212-554-5466, Web Site: http://www.cantelmedical.com/
Copyright
Cantel Medical (NYSE:CMD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Cantel Medical (NYSE:CMD)
Historical Stock Chart
From Jul 2023 to Jul 2024